Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential

Emma C Nilsson1, Fariba Jamshidi, Susanne M C Johansson

  • 1Department of Clinical Microbiology, Division of Virology, Umeå University, Umeå SE-901 85, Sweden.

Journal of Virology
|January 11, 2008
PubMed

Insights

Coxsackievirus A24 variant uses sialic acid as its cellular receptor, a critical step for infection. This finding identifies a potential target for developing new antiviral drugs against this pandemic-potential virus.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Coxsackievirus A24 variant (CVA24v) is a significant cause of acute hemorrhagic conjunctivitis with pandemic potential.
  • The cellular receptor for CVA24v has not been previously identified, hindering the development of targeted antiviral therapies.

Purpose of the Study:

  • To identify the cellular receptor for Coxsackievirus A24 variant (CVA24v).
  • To investigate the role of sialic acid in CVA24v binding and infection.
  • To explore potential therapeutic strategies targeting the identified receptor.

Main Methods:

  • Utilized Chinese Hamster Ovary (CHO) cells deficient in sialic acid expression to assess CVA24v binding and infection.
  • Employed sialic acid-cleaving enzymes and sialic acid-binding lectins to inhibit CVA24v interaction with corneal epithelial cells.
  • Tested the efficacy of soluble, multivalent sialic acid in blocking CVA24v infection.
  • Investigated the role of proteases in CVA24v cell binding to determine receptor characteristics.

Main Results:

  • CVA24v failed to bind and infect CHO cells lacking sialic acid.
  • Sialic acid-cleaving enzymes, sialic acid-binding lectins, and soluble sialic acid significantly inhibited CVA24v binding and infection of corneal epithelial cells.
  • Protease treatment of cells abolished CVA24v binding, indicating the receptor is a sialylated glycoprotein.
  • CVA24v shares the same sialic acid receptor with Enterovirus 70 and Influenza A virus.

Conclusions:

  • Sialic acid is the cellular receptor for Coxsackievirus A24 variant (CVA24v).
  • CVA24v utilizes a sialylated glycoprotein as its receptor, similar to other pathogenic viruses.
  • Sialic acid-based antiviral drugs hold promise for topical treatment of eye infections caused by CVA24v and other viruses using this receptor.

Related Concept Videos

Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...